Filing Details

Accession Number:
0001225208-10-025183
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-17 18:14:28
Reporting Period:
2010-11-16
Filing Date:
2010-11-17
Accepted Time:
2010-11-17 18:14:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192506 R Michael Bowlin One Edwards Way
Irvine CA 92614
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-16 20,000 $11.25 76,928 No 4 M Direct
Common Stock Acquisiton 2010-11-16 6,068 $13.18 82,996 No 4 M Direct
Common Stock Acquisiton 2010-11-16 4,590 $17.43 87,586 No 4 M Direct
Common Stock Disposition 2010-11-16 5,901 $65.31 81,685 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option (Right to Acquire) Disposition 2010-11-16 20,000 $0.00 20,000 $11.25
Common Stock Director Stock Option (Right to Acquire) Disposition 2010-11-16 6,068 $0.00 6,068 $13.18
Common Stock Director Stock Option (Right to Acquire) Disposition 2010-11-16 4,590 $0.00 4,590 $17.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2003-05-11 2011-05-11 No 4 M Direct
0 2001-07-01 2011-07-01 No 4 M Direct
0 2004-07-01 2011-06-30 No 4 M Direct
Footnotes
  1. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  2. This transaction was executed in multiple trades at prices ranging from $65.00 to $65.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.